Hong Kong to Pilot Prioritizing Some Listed Medical Devices
Hong Kong’s MDD announced the start of a pilot program that will give preference to MDACS listed medical devices.
If you are not happy with the results below please do another search
Hong Kong’s MDD announced the start of a pilot program that will give preference to MDACS listed medical devices.
In addition to receiving market authorization for the safety and efficacy of their product, manufacturers wishing to advertise their medical devices, especially Direct to Consumer, may need to also obtain approval for their marketing material.
Hong Kong’s Expedited Approval Scheme has been upgraded from a trial. Approvals from at least 2 GHTF countries plus China.
Medical device manufacturers that are serious about growing sales in Hong Kong/Southeast Asia should consider registration a mandatory step.
Uncertainty. If there is one word that best describes the global outlook during the 2020 pandemic this might be one that everyone can agree on.
Medical device manufacturers that are serious about growing sales in Hong Kong/Southeast Asia should consider registration a mandatory step.
Medical device manufacturers looking to establish or improve sales in the US market should contact our team for market insight and strategy development.